The forecasted expenditure on immunisation programmes in France shows a steady increase from 2024 to 2028. Specifically, the values are as follows:
- 2024: €1.43 billion
- 2025: €1.51 billion
- 2026: €1.58 billion
- 2027: €1.66 billion
- 2028: €1.74 billion
Year-on-Year percentage variations are as follows:
- 2024-2025: 5.59%
- 2025-2026: 4.64%
- 2026-2027: 5.06%
- 2027-2028: 4.82%
Over the last two years (2022-2023), the increase rate supports the continuous trend of rising expenditures.
The Compound Annual Growth Rate (CAGR) over the next 5 years (2024-2028) is approximately 5.01%, reflecting the average yearly increase.
Future Trends to Watch
As we move forward, significant factors influencing this upward trend in healthcare expenditure on immunisation programmes could include advancements in vaccine technology, government policy changes, pandemic preparedness, and public health initiatives. Monitoring these factors will be essential to understanding future expenditure patterns.
